Manulife (Manufacturers Life Insurance)’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,329	Closed	-$141K	–	4397
2017 Q4	$141K	Buy	3,329 +332	+11%	+$14.9K	﹤0.01%	3267
2017 Q3	$165K	Buy	2,997 +200	+7%	+$33.7K	﹤0.01%	3127
2017 Q2	$519K	Buy	2,797 +398	+17%	+$69.8K	﹤0.01%	2255
2017 Q1	$286K	Buy	2,399 +273	+13%	+$28.6K	﹤0.01%	2578
2016 Q4	$212K	Buy	2,126 +82	+4%	+$8.63K	﹤0.01%	2737
2016 Q3	$229K	Sell	2,044 -30	-1%	-$3.6K	﹤0.01%	2670
2016 Q2	$213K	Buy	2,074 +991	+92%	+$99.1K	﹤0.01%	2661
2016 Q1	$99K	Buy	1,083 +779	+256%	+$83.1K	﹤0.01%	3051
2015 Q4	$44	Buy	+304	New	+$39.6K	﹤0.01%	3290

Other funds holding SIOX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SIOX Position: Q1 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2018, closing a stake of 3,329 shares — an estimated $141K sold.

Manulife (Manufacturers Life Insurance) first reported a position in SIOX in Q4 2015 and held it in 9 quarters. The position peaked at $519K in Q2 2017. 81 funds tracked by Wall St. Rank hold SIOX as of Q1 2018.

Manulife (Manufacturers Life Insurance) reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 3,329 Sio Gene Therapies Inc. Common Stock shares in Q1 2018, an estimated $141K.
Manulife (Manufacturers Life Insurance) first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 9 quarters.
Manulife (Manufacturers Life Insurance)'s Sio Gene Therapies Inc. Common Stock position peaked at $519K in Q2 2017.
81 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2018, filed 15 May 2018.